EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A Decade of Decline: The Decreasing Use of Positive Controls Threatens the Reliability of In vitro Cancer Research

Henri van den Berg, Suzanne van Niekerk, Mmbulaheni Happiness Netshimbupfe, Frank van der Kooy iD

Planta Medica · 01.08.2026 · 92 (09) · 869-875

DOI: 10.1055/a-2816-1526 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Planta Medica, erschienen am 01.08.2026. Verfasst von Henri van den Berg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence for Pharmaceutical Sciences (Pharmacen), North-West University, Potchefstroom, South Africa. Hauptthemen laut MEDLINE: Neoplasms, Drug Discovery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractPositive controls are indispensable for validating in vitro cancer bioassays and ensuring reproducibility in cancer drug discovery research. However, evidence suggests their inclusion in in vitro bioassays during drug discovery is declining, undermining assay reliability, reproducibility, and scientific integrity. This mini-review analysed 150 peer-reviewed studies published in 2015, 2020, and 2025 (50 from each year) to evaluate trends in positive control usage within cytotoxicity assays targeting cancer cell lines. Results indicate that only 52% (2015) and 54% (2020) of studies included appropriate positive controls; however, this dropped to a worrying 32% in 2025. The omission was most pronounced in natural product research and studies using high-throughput assays, such as MTT. In addition, reporting of dose-response parameters (e.g., IC₅₀) decreased from 26% to only 16% across the decade. These findings highlight a systemic erosion of methodological rigor, likely driven by publication pressure, limited resources, and a lack of standardised protocols. We recommend the mandatory inclusion of validated positive controls, transparent reporting of preparation and storage conditions, and journal-level enforcement of experimental standards. Reinforcing these practices will improve reproducibility, comparability, and ultimately the translatability of preclinical cancer research outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDrug DiscoveryHumansReproducibility of ResultsCell Line, TumorAnimalsBiological AssayDrug Screening Assays, Antitumor

Autor:innen und Institutionen

  • Centre of Excellence for Pharmaceutical Sciences (Pharmacen), North-West University, Potchefstroom, South Africa.

ORCID-Profile: Frank van der Kooy

Zitieren

APA

van den Berg, H., van Niekerk, S., Netshimbupfe, M. H., & van der Kooy, F. (2026). A Decade of Decline: The Decreasing Use of Positive Controls Threatens the Reliability of In vitro Cancer Research. Planta Medica, 92(09), 869-875. https://doi.org/10.1055/a-2816-1526

Vancouver

van den Berg H, van Niekerk S, Netshimbupfe MH, van der Kooy F. A Decade of Decline: The Decreasing Use of Positive Controls Threatens the Reliability of In vitro Cancer Research. Planta Medica. 2026;92(09):869-875. doi:10.1055/a-2816-1526

BibTeX
@article{vandenBerg2026,
  author = {van den Berg, Henri and van Niekerk, Suzanne and Netshimbupfe, Mmbulaheni Happiness and van der Kooy, Frank},
  title = {A Decade of Decline: The Decreasing Use of Positive Controls Threatens the Reliability of In vitro Cancer Research},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {09},
  pages = {869--875},
  doi = {10.1055/a-2816-1526}
}
Kostenlos starten →